BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36485157)

  • 1. Modern management of Fanconi anemia.
    Dufour C; Pierri F
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):649-657. PubMed ID: 36485157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How I treat MDS and AML in Fanconi anemia.
    Peffault de Latour R; Soulier J
    Blood; 2016 Jun; 127(24):2971-9. PubMed ID: 27020090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia.
    Yabe M; Koike T; Ohtsubo K; Imai E; Morimoto T; Takakura H; Koh K; Yoshida K; Ogawa S; Ito E; Okuno Y; Muramatsu H; Kojima S; Matsuo K; Mori M; Hira A; Takata M; Yabe H
    Ann Hematol; 2019 Feb; 98(2):271-280. PubMed ID: 30368588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Fanconi anemia beyond childhood.
    Olson TS
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):556-562. PubMed ID: 38066849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia.
    Savage SA; Walsh MF
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):657-668. PubMed ID: 30047418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: A retrospective analysis on behalf of EBMT group.
    Giardino S; de Latour RP; Aljurf M; Eikema DJ; Bosman P; Bertrand Y; Tbakhi A; Holter W; Bornhäuser M; Rössig C; Burkhardt B; Zecca M; Afanasyev B; Michel G; Ganser A; Alseraihy A; Ayas M; Uckan-Cetinkaya D; Bruno B; Patrick K; Bader P; Itälä-Remes M; Rocha V; Jubert C; Diaz MA; Shaw PJ; Junior LGD; Locatelli F; Kröger N; Faraci M; Pierri F; Lanino E; Miano M; Risitano A; Robin M; Dufour C;
    Am J Hematol; 2020 Jul; 95(7):809-816. PubMed ID: 32267023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome in patients with Fanconi anemia who received hematopoietic stem cell transplantation: a retrospective nationwide analysis.
    Yabe M; Morio T; Tabuchi K; Tomizawa D; Hasegawa D; Ishida H; Yoshida N; Koike T; Takahashi Y; Koh K; Okamoto Y; Sano H; Kato K; Kanda Y; Goto H; Takita J; Miyamura T; Noguchi M; Kato K; Hashii Y; Astuta Y; Yabe H
    Int J Hematol; 2021 Jan; 113(1):134-144. PubMed ID: 32949371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypes of adults with Fanconi anaemia.
    Wang YM; Loveless M; Miller E; Nelson AS; Mehta PA; Davies SM; Myers KC
    Br J Haematol; 2023 Apr; 201(1):133-139. PubMed ID: 36513378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematological consequences of a FANCG founder mutation in Black South African patients with Fanconi anemia.
    Feben C; Kromberg J; Wainwright R; Stones D; Poole J; Haw T; Krause A
    Blood Cells Mol Dis; 2015 Mar; 54(3):270-4. PubMed ID: 25477267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fanconi anemia.
    Soulier J
    Hematology Am Soc Hematol Educ Program; 2011; 2011():492-7. PubMed ID: 22160080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi anemia and the development of leukemia.
    Alter BP
    Best Pract Res Clin Haematol; 2014; 27(3-4):214-21. PubMed ID: 25455269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic research in the crystal chromosome disease Fanconi anemia.
    Minguillón J; Surrallés J
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt A):104-108. PubMed ID: 30389152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
    Mehta PA; Harris RE; Davies SM; Kim MO; Mueller R; Lampkin B; Mo J; Myers K; Smolarek TA
    Cancer Genet Cytogenet; 2010 Dec; 203(2):180-6. PubMed ID: 21156231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children.
    Murillo-Sanjuán L; González-Vicent M; Argilés Aparicio B; Badell Serra I; Rodríguez Villa A; Uria Oficialdegui ML; López-Duarte M; Beléndez-Bieler C; Sastre Urgelles A; Sevilla Navarro J; Diaz-de-Heredia C;
    Bone Marrow Transplant; 2021 May; 56(5):1213-1216. PubMed ID: 33303901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.
    Mehta PA; Davies SM; Leemhuis T; Myers K; Kernan NA; Prockop SE; Scaradavou A; O'Reilly RJ; Williams DA; Lehmann L; Guinan E; Margolis D; Baker KS; Lane A; Boulad F
    Blood; 2017 Apr; 129(16):2308-2315. PubMed ID: 28179273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK Cell Development and Function in Patients with Fanconi Anemia.
    Hashemi E; Bjorgaard S; Wang D; Uyemura B; Riese M; Thakar MS; Malarkannan S
    Crit Rev Immunol; 2021; 41(2):35-44. PubMed ID: 34348001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization.
    Nicoletti E; Rao G; Bueren JA; Río P; Navarro S; Surrallés J; Choi G; Schwartz JD
    Ann Hematol; 2020 May; 99(5):913-924. PubMed ID: 32065290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.
    Chao MM; Kuehl JS; Strauss G; Hanenberg H; Schindler D; Neitzel H; Niemeyer C; Baumann I; von Bernuth H; Rascon J; Nagy M; Zimmermann M; Kratz CP; Ebell W
    Ann Hematol; 2015 Aug; 94(8):1311-8. PubMed ID: 25862235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis on phenotype and genetic basis of Chinese Fanconi anemia patients: dismal outcomes call for nationwide studies.
    Nie D; Zhang J; Wang F; Zhang W; Liu L; Chen X; Zhang Y; Cao P; Xiong M; Wang T; Wu P; Ma X; Tian W; Wang M; Chen KN; Liu H
    BMC Med Genet; 2020 Jun; 21(1):118. PubMed ID: 32487094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSCT for Fanconi anemia in children: factors that influence early and late results.
    Dalle JH
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S51-3. PubMed ID: 18978745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.